Search for: "Noonan, in Re"
Results 101 - 120
of 285
Sorted by Relevance
|
Sort by Date
22 Dec 2008, 11:28 pm
Noonan -- The Federal Circuit engaged in judicial parsimony last week, in affirming the decision below that the asserted claims of U.S. [read post]
17 Apr 2009, 8:14 pm
Kevin Noonan, Andrew Williams, and Donald Zuhn of McDonnell Boehnen Hulbert and Berghoff LLP will discuss recent decisions on obviousness (In re Kubin), written description (Ariad v. [read post]
8 Sep 2011, 9:59 pm
Noonan -- Accompanying the Federal Circuit's majority decision in Classen Immunotherapies, Inc. v. [read post]
16 Dec 2009, 9:59 pm
Noonan -- Until now, the major bones of contention over the Senate's patent "reform" bill (S. 515) have centered around two provisions: putting in place statutory language governing how damages are to be assessed, and instituting a post-grant review system modeled on the European opposition, and that will be more extensive than current re-examinations. [read post]
26 Apr 2009, 6:02 pm
Noonan -- Two pronouncements, one from the Supreme Court and the other from the Federal Circuit, portend the parlous state that could await American innovation should judges come to believe that that their judgment is as sound as that of actual innovators. [read post]
28 Aug 2012, 9:14 pm
§ 271(e)(2) are anticompetitve and barred by Federal antitrust law, in In re K-Dur Antitrust Litigation. [read post]
8 May 2015, 8:45 am
They’re like . [read post]
1 Apr 2013, 9:59 pm
Noonan -- The Supreme Court heard oral argument in Federal Trade Commission v. [read post]
18 Jul 2017, 9:58 pm
Cir. 2017)"; "In re Nuvasive (Fed. [read post]
18 Aug 2016, 9:36 pm
In re Gartside,... [read post]
13 Jun 2016, 8:19 pm
And had anyone bet on the Court reversing (formally, vacating and remanding) the Federal Circuit's In re Seagate Tech. [read post]
4 Nov 2014, 9:58 pm
Noonan -- Late last week, District Court Judge Peter Sheridan (D.N.J.) dismissed with prejudice the complaint for antitrust injury by the so-called "End Payor Class Purchasers" against the parties in previous ANDA litigation in the case styled In re Lipitor Antitrust Litigation (Order). [read post]
10 Feb 2015, 9:59 pm
§ 1407 and captioned In Re: BRCA1- and BRCA2-Based Hereditary Cancer Test Patent Litigation; see "Panel on Multidistrict Litigation Consolidates Myriad Cases in Utah District Court"). [read post]
7 Mar 2023, 9:16 pm
Noonan -- The Supreme Court's (re)consideration of the enablement requirement expected in its decision later this year in Amgen v. [read post]
27 Jul 2023, 9:20 pm
Noonan -- In earlier times, the Federal Circuit, responding to efforts by the U.S. [read post]
24 Mar 2022, 7:40 pm
" The effects of such a waiver are being debated by those against it (mostly members of industry having vaccine-related IP protection and industries making vaccines) and in favor (NGOs, such as Médecins Sans Frontières) and, of course, the governments who... [read post]
31 Mar 2015, 9:59 pm
Noonan -- Earlier this month, the Federal Circuit affirmed a District Court judgment of obviousness in ANDA litigation under the Hatch Waxman Act having a long provenance of earlier litigation, in Senju Pharmaceutical Co., Ltd. v. [read post]
7 Apr 2014, 9:59 pm
Noonan -- Applying the doctrine of claim preclusion (previously termed res judicata), a fractured majority of the Federal Circuit held that prior ANDA litigation to final judgment precluded reassertion of amended claims in the same patents against the same products after reexamination that narrowed the scope of the claims to avoid an obviousness determination. [read post]
13 Feb 2023, 9:12 pm
Noonan -- A change in the weather is known to be extreme But what's the sense of changing horses in midstream? [read post]
16 Sep 2009, 9:59 pm
Noonan -- Over the past few years, Federal Circuit decisions in In re Bilski and Classen Immunotherapeutics, Inc. v. [read post]
